Intense p53 staining is a valuable prognostic indicator for poor prognosis in medulloblastoma/central nervous system primitive neuroectodermal tumors.
about
Increased p53 immunopositivity in anaplastic medulloblastoma and supratentorial PNET is not caused by JC virusBRCA2 is required for neurogenesis and suppression of medulloblastomaClassifying the medulloblastoma: insights from morphology and molecular genetics.Large cell anaplastic medulloblastoma metastatic to the scalp: tumor and derived stem-like cells featuresPrognosis-related molecular markers in pediatric central nervous system tumors.PI3K pathway regulates survival of cancer stem cells residing in the perivascular niche following radiation in medulloblastoma in vivo.Molecular diagnostics in embryonal brain tumors.Recurrent genomic alterations characterize medulloblastoma arising from DNA double-strand break repair deficiency.HD-MB03 is a novel Group 3 medulloblastoma model demonstrating sensitivity to histone deacetylase inhibitor treatment.A study of histopathological spectrum and expression of Ki-67, TP53 in primary brain tumors of pediatric age group.p53 expression predicts dismal outcome for medulloblastoma patients with metastatic disease.Clinicopathological analysis of nine consecutive central nervous system primitive neuroectodermal tumors in a single institute.Immunohistochemical expression of markers Ki-67, neun, synaptophysin, p53 and HER2 in medulloblastoma and its correlation with clinicopathological parameters.Recurrence in medulloblastoma - influence of clinical, histological and immunohistochemical factors.Morphophenotypic variation predicts clinical behavior in childhood non-desmoplastic medulloblastomas.TrkA expression is associated with an elevated level of apoptosis in classic medulloblastomas.
P2860
Q24801678-52C9C3FD-6CE1-4044-9A8F-D2E869F7A55DQ28590758-F48F46A3-E4E1-4FB9-A45A-F4709F2015B3Q34783428-E7F7483C-87CA-445B-95B3-B8788F53BE1EQ35150189-383187F2-7F9C-4604-9654-D660F4D5D0A8Q35996275-80047B82-3B4B-4121-A117-62CD5D08012EQ36453531-D96A7D44-5EC3-4079-B488-A05D6CDC0B16Q36619093-CF5A9D79-4433-4776-9C8A-ED27F2386B10Q37100889-8F56DF12-AADE-4D7D-8D0D-504E8661D4D0Q39262034-E464385C-F44B-4BC7-9DCF-3A8C30355BAAQ41901263-0FE14E76-364A-425C-A675-A6E5C56468F1Q44635070-67C4B2C9-77EE-44EA-B59C-5EE11B6E2C62Q44825303-C653968B-2C12-45DF-BEEB-0A34854AC4FAQ49056530-1DA3D6ED-1E4E-405E-BD80-A5746064E8BFQ51771306-BB51459B-2A90-43D8-AEBC-45B6776E3DE4Q53300055-55332972-8801-4332-8611-630285DEAF77Q55470093-6B0EC5F8-3DA2-44F8-8778-E6A24D5DFE7B
P2860
Intense p53 staining is a valuable prognostic indicator for poor prognosis in medulloblastoma/central nervous system primitive neuroectodermal tumors.
description
2001 nî lūn-bûn
@nan
2001年の論文
@ja
2001年学术文章
@wuu
2001年学术文章
@zh
2001年学术文章
@zh-cn
2001年学术文章
@zh-hans
2001年学术文章
@zh-my
2001年学术文章
@zh-sg
2001年學術文章
@yue
2001年學術文章
@zh-hant
name
Intense p53 staining is a valu ...... mitive neuroectodermal tumors.
@en
Intense p53 staining is a valu ...... mitive neuroectodermal tumors.
@nl
type
label
Intense p53 staining is a valu ...... mitive neuroectodermal tumors.
@en
Intense p53 staining is a valu ...... mitive neuroectodermal tumors.
@nl
prefLabel
Intense p53 staining is a valu ...... mitive neuroectodermal tumors.
@en
Intense p53 staining is a valu ...... mitive neuroectodermal tumors.
@nl
P2093
P356
P1476
Intense p53 staining is a valu ...... mitive neuroectodermal tumors.
@en
P2093
B Azzarelli
J F Montebello
R T Woodburn
P2888
P356
10.1023/A:1010691330670
P577
2001-03-01T00:00:00Z
P6179
1044716471